Swiss National Bank 2seventy Bio, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$8.45 - $12.48 $30,419 - $44,928	3,600 Added 3.8%	98,302 $994,000
Q1 2023 May 10, 2023	BUY	$9.21 - $14.98 $72,759 - $118,342	7,900 Added 9.1%	94,702 $965,000
Q4 2022 Feb 08, 2023	BUY	$8.57 - $17.0 $24,853 - $49,300	2,900 Added 3.46%	86,802 $813,000
Q1 2022 May 09, 2022	BUY	$11.67 - $26.72 $399,114 - $913,824	34,200 Added 68.81%	83,902 $1.43 Million
Q4 2021 Feb 08, 2022	BUY	$13.77 - $42.56 $684,396 - $2.12 Million	49,702 New	49,702 $1.27 Million

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $137M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.